Literature DB >> 21335956

Predisposition to aneuploidy in the oocyte.

F Vialard1, F Boitrelle, D Molina-Gomes, J Selva.   

Abstract

While the incidence of predisposition to aneuploidy in the oocyte increases with age, there is also evidence of increased incidence in young women with recurrent miscarriage, recurrent aneuploidy, or recurrent implantation failure after in vitro fertilization. There is evidence from mouse models and from observations in humans that follicle-stimulating hormone (FSH) probably has a direct or indirect effect on the occurrence of oocyte aneuploidy. It seems that increased endogenous or exogenous FSH could induce meiotic disruption. Although the effect of FSH may explain the age-related increase in aneuploidy rate, many questions remain regarding young women, even if their FSH level is sometimes increased. Disruption of meiotic gene expression caused by exposure to environmental contaminants or by gene defects could also predispose to oocyte aneuploidy. Such abnormalities could impact on the oocyte pool, recombination and synapsis during fetal life, or oocyte growth.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21335956     DOI: 10.1159/000324231

Source DB:  PubMed          Journal:  Cytogenet Genome Res        ISSN: 1424-8581            Impact factor:   1.636


  7 in total

1.  Serum markers of ovarian reserve and ovarian histology in adult mice treated with cyclophosphamide in pre-pubertal age.

Authors:  Laura Detti; Rebecca A Uhlmann; Meifen Lu; Michael P Diamond; Ghassan M Saed; Nicole M Fletcher; Jie Zhang; Lucy J Williams
Journal:  J Assist Reprod Genet       Date:  2013-09-24       Impact factor: 3.412

2.  Follicular fluid protein content (FSH, LH, PG4, E2 and AMH) and polar body aneuploidy.

Authors:  I Hammoud; F Vialard; M Bergere; M Albert; D Molina Gomes; M Adler; L Malagrida; M Bailly; R Wainer; J Selva
Journal:  J Assist Reprod Genet       Date:  2012-08-14       Impact factor: 3.412

3.  Dual diagnoses in 152 patients with Turner syndrome: Knowledge of the second condition may lead to modification of treatment and/or surveillance.

Authors:  Kelly L Jones; Erin A McNamara; Mauro Longoni; Danny E Miller; Mersedeh Rohanizadegan; Laura A Newman; Frances Hayes; Lynne L Levitsky; Betty L Herrington; Angela E Lin
Journal:  Am J Med Genet A       Date:  2018-08-06       Impact factor: 2.802

4.  Preimplantation genetic screening: a practical guide.

Authors:  Paul R Brezina; Raymond W Ke; William H Kutteh
Journal:  Clin Med Insights Reprod Health       Date:  2013-02-27

5.  Human frozen-thawed blastocyst morphokinetics observed using time-lapse cinematography reflects the number of trophectoderm cells.

Authors:  Takuya Iwasawa; Kazumasa Takahashi; Mayumi Goto; Mibuki Anzai; Hiromitsu Shirasawa; Wataru Sato; Yukiyo Kumazawa; Yukihiro Terada
Journal:  PLoS One       Date:  2019-01-16       Impact factor: 3.240

6.  Comparative Cytogenetic Analysis of Spontaneous Abortions in Recurrent and Sporadic Pregnancy Losses.

Authors:  Tatiana V Nikitina; Elena A Sazhenova; Ekaterina N Tolmacheva; Natalia N Sukhanova; Anna A Kashevarova; Nikolay A Skryabin; Stanislav A Vasilyev; Tatiana N Nemtseva; Sergey Y Yuriev; Igor N Lebedev
Journal:  Biomed Hub       Date:  2016-04-27

7.  Estradiol (E 2) Reduction Adversely Affect the Embryo Quality and Clinical Outcomes of In Vitro Fertilization and Embryo transfer (IVF-ET).

Authors:  Jing Cheng; Shuangqing Yang; Huaqing Ma; Yingxiu Liang; Junzhao Zhao
Journal:  J Healthc Eng       Date:  2022-04-07       Impact factor: 3.822

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.